IDEAS home Printed from https://ideas.repec.org/a/gam/jijerp/v21y2024i3p325-d1354878.html
   My bibliography  Save this article

From Acute Infection to Prolonged Health Consequences: Understanding Health Disparities and Economic Implications in Long COVID Worldwide

Author

Listed:
  • Jaleel Jerry G. Sweis

    (Division of Cardiology, Department of Medicine, University of Illinois Chicago, Chicago, IL 60612, USA
    These authors have contributed equally to this work and share the first authorship.)

  • Fatima Alnaimat

    (Department of Internal Medicine, Division of Rheumatology, School of Medicine, University of Jordan, Amman 11942, Jordan
    These authors have contributed equally to this work and share the first authorship.)

  • Valeria Esparza

    (Department of Medicine, University of Illinois Chicago, Chicago, IL 60612, USA
    These authors have contributed equally to this work and share second authorship.)

  • Supritha Prasad

    (Department of Medicine, University of Illinois Chicago, Chicago, IL 60612, USA
    These authors have contributed equally to this work and share second authorship.)

  • Abeera Azam

    (Department of Internal Medicine, The University of Texas Health Science Center at Tyler, Tyler, TX 75701, USA
    These authors have contributed equally to this work and share third authorship.)

  • Zeel Modi

    (Department of Medicine, University of Illinois Chicago, Chicago, IL 60612, USA
    These authors have contributed equally to this work and share third authorship.)

  • Mina Al-Awqati

    (Division of Rheumatology, Department of Medicine, University of Illinois Chicago, Chicago, IL 60612, USA
    These authors have contributed equally to this work and share fourth authorship.)

  • Pim Jetanalin

    (Division of Rheumatology, Department of Medicine, University of Illinois Chicago, Chicago, IL 60612, USA
    These authors have contributed equally to this work and share fourth authorship.)

  • Nadia J. Sweis

    (Department of Business Administration, King Talal School of Business Technology, Princess Sumaya University for Technology, Amman 11942, Jordan)

  • Christian Ascoli

    (Department of Medicine, Division of Pulmonary Critical Care Sleep and Allergy, University of Illinois Chicago, Chicago, IL 60612, USA)

  • Richard M. Novak

    (Division of Infectious Diseases, University of Illinois, Chicago, IL 60612, USA)

  • Israel Rubinstein

    (Department of Medicine, Division of Pulmonary Critical Care Sleep and Allergy, University of Illinois Chicago, Chicago, IL 60612, USA)

  • Ilias C. Papanikolaou

    (Department of Respiratory Medicine, Sarcoidosis Clinic, Corfu General Hospital, 49100 Corfu, Greece)

  • Nadera Sweiss

    (Division of Rheumatology, Department of Medicine, University of Illinois Chicago, Chicago, IL 60612, USA
    Department of Internal Medicine, School of Medicine, University of Jordan, Amman 11942, Jordan)

Abstract

The COVID-19 pandemic has resulted in a growing number of patients experiencing persistent symptoms and physiological changes after recovering from acute SARS-CoV-2 infection, known as Long COVID. Long COVID is characterized by recurring symptoms and inflammation across multiple organ systems. Diagnosis can be challenging, influenced by factors like demographics, comorbidities, and immune responses. Long COVID impacts various organ systems and can have neuropsychological effects. Health disparities, particularly related to race, contribute to a higher burden of infection and ongoing symptoms in minority populations. Managing Long COVID entails addressing a spectrum of symptoms that encompass physical, cognitive, and psychological aspects. The recovery period for patients with Long COVID can vary significantly, influenced by factors like the severity of the disease, hospitalization, comorbidities, and age. Currently, there are no universally effective treatments, although certain interventions show promise, necessitating further research. Self-management and rehabilitation programs can provide relief, but more research is needed to establish their effectiveness. Preventive measures such as vaccination and the use of antiviral medications and metformin. It is imperative to conduct further research to develop evidence-based guidelines and gain a better understanding of the long-term implications of COVID-19. Long COVID could have substantial economic impact on the labor market, productivity, healthcare expenditures, and overall economic growth. To address the challenges patients with long-term complications face, there is a focus on strategies like promoting telework and flexible work arrangements to accommodate diverse symptoms, particularly chronic fatigue and other Long COVID effects. In conclusion, this review emphasizes the multifaceted complexity of Long COVID and the ongoing need to address its potential long-term health and economic impacts.

Suggested Citation

  • Jaleel Jerry G. Sweis & Fatima Alnaimat & Valeria Esparza & Supritha Prasad & Abeera Azam & Zeel Modi & Mina Al-Awqati & Pim Jetanalin & Nadia J. Sweis & Christian Ascoli & Richard M. Novak & Israel R, 2024. "From Acute Infection to Prolonged Health Consequences: Understanding Health Disparities and Economic Implications in Long COVID Worldwide," IJERPH, MDPI, vol. 21(3), pages 1-18, March.
    • Handle: RePEc:gam:jijerp:v:21:y:2024:i:3:p:325-:d:1354878
    as

    Download full text from publisher

    File URL: https://www.mdpi.com/1660-4601/21/3/325/pdf
    Download Restriction: no
    File URL: https://www.mdpi.com/1660-4601/21/3/325/
    Download Restriction: no
    ---><---

    References listed on IDEAS

    as
    1. Jonathan Colmer, 2020. "What is the meaning of (statistical) life? Benefit–cost analysis in the time of COVID-19," Oxford Review of Economic Policy, Oxford University Press and Oxford Review of Economic Policy Limited, vol. 36(Supplemen), pages 56-63.
    2. Nadia J. Sweis, 2022. "Revisiting the value of a statistical life: an international approach during COVID-19," Risk Management, Palgrave Macmillan, vol. 24(3), pages 259-272, September.
    Full references (including those not matched with items on IDEAS)

    Most related items

    These are the items that most often cite the same works as this one and are cited by the same works as this one.
    1. Virat Agrawal & Neeraj Sood & Christopher M. Whaley, 2023. "The Impact of the Global COVID-19 Vaccination Campaign on All-Cause Mortality," NBER Working Papers 31812, National Bureau of Economic Research, Inc.
    2. Nicolò Gatti & Beatrice Retali, 2021. "Fighting the spread of Covid-19 : was the Swiss lockdown worth it?," IdEP Economic Papers 2101, USI Università della Svizzera italiana.
    3. Noghanibehambari, Hamid & Fletcher, Jason, 2023. "Long-Term Health Benefits of Occupational Licensing: Evidence from Midwifery Laws," Journal of Health Economics, Elsevier, vol. 92(C).
    4. Cardoso, Diego S. & Dahis, Ricardo, 2024. "Calculating the economic value of non-marginal mortality risk reductions," Economics Letters, Elsevier, vol. 237(C).
    5. Jose Valderrama & Javier Olivera, 2023. "The effects of social pensions on mortality among the extreme poor elderly," LISER Working Paper Series 2023-05, Luxembourg Institute of Socio-Economic Research (LISER).
    6. Leiva-Perez William H., 2024. "Quantification of the Economic Burden of Premature Mortality: The Case for the Three Least and Most Burdensome Countries within the European Union," Proceedings of the International Conference on Business Excellence, Sciendo, vol. 18(1), pages 3222-3234.
    7. Rachel Glennerster & Christopher M. Snyder & Brandon Joel Tan, 2023. "Calculating the Costs and Benefits of Advance Preparations for Future Pandemics," IMF Economic Review, Palgrave Macmillan;International Monetary Fund, vol. 71(3), pages 611-648, September.
    8. James Broughel & Michael Kotrous, 2021. "The benefits of coronavirus suppression: A cost-benefit analysis of the response to the first wave of COVID-19 in the United States," PLOS ONE, Public Library of Science, vol. 16(6), pages 1-20, June.
    9. James K. Hammitt, 2023. "Consistent valuation of a reduction in mortality risk using values per life, life year, and quality‐adjusted life year," Health Economics, John Wiley & Sons, Ltd., vol. 32(9), pages 1964-1981, September.
    10. Fletcher, Jason & Noghanibehambari, Hamid, 2024. "The siren song of cicadas: Early-life pesticide exposure and later-life male mortality," Journal of Environmental Economics and Management, Elsevier, vol. 123(C).

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:gam:jijerp:v:21:y:2024:i:3:p:325-:d:1354878. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: MDPI Indexing Manager (email available below). General contact details of provider: https://www.mdpi.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.